Learn more about this year’s event on Monday, April 27, 2020
Dr. Marshall talks with Today Show about why colon cancer is on the rise in young patients
Relentlessly fighting a smarter war against GI cancer by partnering with patients based on their unique needs, the Ruesch Center is committed to providing you with the highest standard of care and individualized cures.
Search our current GI clinical trials offered through the MedStar Georgetown Cancer Institute
Gastrointestinal (GI) Cancers are the most common and most fatal of all cancers. The Ruesch Center will re-focus national efforts on curing this deadly set of diseases.
Targeted Therapies Showing Promise in Colorectal Cancer
February 6th, 2020
Benjamin Weinberg, MD, assistant professor of medicine and attending physician at MedStar Georgetown University Hospital, Washington, DC, discusses novel agents that may impact the treatment landscape for colorectal cancer (CRC) once made available in the community setting.
Georgetown Lombardi Clinical Trial Helps Advance Use of Immunotherapy in Liver Cancer
January 6th, 2020
In August of 2016, Dan Hilton arrived at MedStar Georgetown University Hospital to be evaluated for a liver transplant. He had been diagnosed with cirrhosis, the result of a hepatitis C infection contracted many years earlier. After multiple tests, he received unexpected news; the doctors found tumors on his liver.
Understanding the Microbiome and its Effect on Treatment of Patients with Colorectal Cancer
January 6th, 2020
In an interview with Targeted Oncology at the 2019 Ruesch Center Symposium, Weinberg shared key points from his discussion on mining the microbiome in patients with CRC and summarized the treatment landscape for patients with metastatic disease. He also discussed an upcoming basket trial that uses liquid biopsies to place patients on treatment plans that will be most effective for their individual needs.
Sign Up to receive all Ruesch updates directly in your Inbox
We will deliver our quarterly newsletter, monthly updates and other announcements to your Inbox with information on upcoming special events, current clinical trials and cutting edge research and trends in the GI cancer field.
